{
  "ptid_time": "002_S_4270_2015-12-04",
  "img_path": "/data/qiuhui/data/adni/images/002_S_4270/2015-12-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 41,136 mm³, 46.6% above the reference mean. With a Z-score of 1.07 (85.7th percentile), this represents mild enlargement; hippocampal volume measures 5,980 mm³, 15.9% below the reference mean. With a Z-score of -1.46 (7.2th percentile), this represents mild atrophy; whole brain volume measures 1,017,880 mm³, 4.4% above the reference mean. With a Z-score of 0.56 (71.2th percentile), this represents normal volume ; entorhinal cortex volume measures 2,734 mm³, 25.6% below the reference mean. With a Z-score of -1.57 (5.8th percentile), this represents moderate atrophy; fusiform gyrus volume measures 18,371 mm³, 8.0% above the reference mean. With a Z-score of 0.73 (76.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,891 mm³, 6.7% below the reference mean. With a Z-score of -0.58 (28.1th percentile), this represents normal volume . ",
  "text_data": "Age is 78.6 years. Gender is Female. Education: 16 years. MMSE: 27.0. MoCA: 25.0. Logical Memory: 4.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.46 SUVR (significant elevated); Amyloid beta: 411.40 pg/mL (moderate reduced); Total tau: 189.00 pg/mL (normal ); Phosphorylated tau: 19.91 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data reveals mild hippocampal and moderate entorhinal cortex atrophy, both key regions affected in Alzheimer's disease (AD), alongside elevated amyloid (AV45) and moderately reduced Aβ, supporting AD pathology. However, cognitive scores (MMSE 27, MoCA 25) are near-normal, suggesting preserved function despite structural changes.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology).  \n**Confidence:** **Medium** (cognitive scores are borderline, but biomarker/imaging evidence strongly suggests early AD continuum).  \n\n*Note: The discrepancy between imaging/biomarkers and cognitive performance places this in MCI, but progression to dementia is likely given the AD signature (entorhinal/hippocampal atrophy + amyloid positivity).*",
  "timestamp": "2025-07-25T20:27:17.119312"
}